Survivin: an inhibitor of apoptosis in pediatric cancer

Pediatric Blood & Cancer
Jason FangusaroRachel A Altura

Abstract

Survivin is an inhibitor of apoptosis protein (IAP) expressed in a large number of adult malignancies. Its expression levels correlate with more aggressive disease and poor clinical outcome in many of these tumors. As its expression is restricted in normal adult differentiated tissues, it has become of great interest as both a tumor prognostic marker and as a potential biologic target for future anti-cancer therapies. Survivin expression and Survivin-based therapies have been examined in many of the more common pediatric malignancies. We present an overview of Survivin function and current research exploring its biologic and therapeutic roles in pediatric tumors.

References

Sep 24, 1994·Lancet·J Pritchard, J A Hickman
Aug 1, 1997·Nature Medicine·G AmbrosiniD C Altieri
Jun 6, 1998·The Journal of Biological Chemistry·G AmbrosiniD C Altieri
Jul 17, 1999·Trends in Cell Biology·L K Miller
May 29, 2000·Molecular Human Reproduction·R KonnoA Yajima
Nov 25, 2000·British Journal of Haematology·C AdidaH Dombret
Jan 3, 2001·The Journal of Cell Biology·D A SkoufiasR L Margolis
Jan 11, 2001·Journal of Pediatric Surgery·S TakamizawaA Sandler
Feb 15, 2001·International Journal of Cancer. Journal International Du Cancer·J LuM Wu
Nov 21, 2001·The Journal of Biological Chemistry·William H HoffmanMaureen Murphy
Dec 1, 2001·Journal of Clinical Pathology·N Bown
Feb 15, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Arnab ChakravartiJay S Loeffler
Mar 21, 2002·Nature Reviews. Cancer·T Soussi, C Béroud
Jun 4, 2002·Nature Reviews. Molecular Cell Biology·Guy S Salvesen, Colin S Duckett
Jun 19, 2002·Acta Neuropathologica·Tsutomu SasakiGregory A Helm
Sep 5, 2002·Nature Reviews. Cancer·Suzanne Cory, Jerry M Adams
Sep 18, 2002·The Journal of Pharmacology and Experimental Therapeutics·Muxiang ZhouHarry W Findley
Dec 13, 2002·Cell Death and Differentiation·C MahotkaC D Gerharz
Jan 2, 2003·Nature Reviews. Cancer·Dario C Altieri
Mar 5, 2003·Cancer Treatment and Research·Lili Yamasaki
Apr 25, 2003·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·K TriebK R Shroyer
Jun 5, 2003·Journal of Cell Science·Ana CarvalhoSally P Wheatley
Jun 14, 2003·The EMBO Journal·Susanne M A LensRené H Medema
Jun 26, 2003·Archives of Pathology & Laboratory Medicine·B K Kleinschmidt-DeMastersKenneth R Shroyer
Jul 11, 2003·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S PaydasR Burgut
Sep 6, 2003·British Journal of Haematology·Sandra SiegelMatthias Zeis
Oct 22, 2003·Journal of Neurosurgery·Yoshitaka YamadaShin-Ichi Miyatake

❮ Previous
Next ❯

Citations

Aug 24, 2011·Endocrine-related Cancer·Fieke LamersJan J Molenaar
Feb 25, 2014·Cancer Letters·Kalliopi Ch AthanasoulaMarina Mantzourani
Dec 22, 2011·Cancer Letters·Roser FranciscoSantiago Ambrosio
Oct 4, 2012·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·Sam KalungiLeif Bostad
Jul 6, 2014·British Journal of Haematology·Smita DandekarWilliam L Carroll
Sep 23, 2014·Oncogene·S N BrunR J Wechsler-Reya
Nov 18, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Fieke LamersJan J Molenaar
Jan 19, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Tobias M DantonelloEwa Koscielniak
Feb 13, 2019·International Journal of Clinical Oncology·Abdolkarim Moazeni-RoodiMohammad Hashemi
Nov 23, 2019·Minerva medica·Bianca BiancoErik Montagna
Aug 10, 2017·Journal of Immunology Research·Rahel Mascha StammerCatharina I Delebinski
Jun 3, 2021·Pediatric Hematology and Oncology·Afaf Mohammad MahmoudLobna Mohamed Shalaby
Apr 25, 2018·ACS Applied Materials & Interfaces·Katarzyna RatajczakMagdalena Stobiecka

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis